The Healthcare Investor

Latest from The Healthcare Investor - Page 17

Renovus Capital Partners has announced it has closed its fourth private equity fund.

The fund, Renovus Capital Partners IV Core Buyout, was oversubscribed and had total capital commitments of $875 million. It will focus on control investments in founder-owned small and mid-sized businesses in the lower middle market.

Renovus, based in Philadelphia, is a

Shore Capital Partners has announced the closing of its inaugural Healthcare Advantage Fund.

The fund will target healthcare companies in the lower middle market.

In conjunction with announcing the close of the Advantage Fund, Shore Capital announced the close of two other non-healthcare-focused funds. The three new funds each exceeded their targets and together represent

By Kevin Madagan

Waud Capital Partners (WCP) has announced the acquisition of Science Exchange.

Science Exchange, founded in 2011 and based in San Francisco, is a provider of life sciences procurement and supplier management software-as-a-service (SaaS) solutions.

WCP, founded in 1993 and based in Chicago, seeks control equity investments in middle market companies

Northlane Capital Partners (NCP) has announced the sale of PAR Excellence Systems to OceanSound Partners.

PAR Excellence, founded in 1992 and based in Cincinnati, is a provider of supply chain integrity and cost management solutions to the healthcare industry.

NCP, based in Bethesda, Maryland, is a middle market private equity firm focused on

Genstar Capital has announced a strategic majority investment in Flourish Research, according to a news release.

Flourish, founded in 2001 and based in Apex, North Carolina, is a multi-site clinical trial organization focused on areas including cardiovascular, metabolic, neuroscience and infectious disease therapeutic areas.

Genstar Capital, based in San Francisco, is a private